Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126057823 | 12605782 | 3 | F | 20160110 | 20160906 | 20160729 | 20160917 | EXP | IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120867 | RANBAXY | 81.94 | YR | F | Y | 0.00000 | 20160917 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126057823 | 12605782 | 1 | PS | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG DAILY | U | U | 200794 | 40 | MG | ||||||
126057823 | 12605782 | 2 | SS | Tripliam 10 mg/2.5 mg/5 mg | AMLODIPINEINDAPAMIDEPERINDOPRIL | 1 | Oral | 17.5 MG, DAILY | U | U | 0 | 17.5 | MG | TABLET | |||||
126057823 | 12605782 | 3 | SS | TRIATEC 5 MG | RAMIPRIL | 1 | Oral | 5 MG DAILY | U | U | 0 | 5 | MG | TABLET | |||||
126057823 | 12605782 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
126057823 | 12605782 | 5 | C | ASCRIPTIN | ASPIRIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
126057823 | 12605782 | 6 | C | ATORVASTATINA 80 MG | 2 | Unknown | UNK | U | U | 0 | FILM-COATED TABLET | ||||||||
126057823 | 12605782 | 7 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
126057823 | 12605782 | 8 | C | LENTOKALIUM | 2 | Unknown | UNK | U | U | 0 | |||||||||
126057823 | 12605782 | 9 | C | NORMIX | RIFAXIMIN | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126057823 | 12605782 | 1 | Product used for unknown indication |
126057823 | 12605782 | 2 | Essential hypertension |
126057823 | 12605782 | 3 | Essential hypertension |
126057823 | 12605782 | 4 | Product used for unknown indication |
126057823 | 12605782 | 5 | Product used for unknown indication |
126057823 | 12605782 | 6 | Product used for unknown indication |
126057823 | 12605782 | 7 | Product used for unknown indication |
126057823 | 12605782 | 8 | Product used for unknown indication |
126057823 | 12605782 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126057823 | 12605782 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126057823 | 12605782 | Diarrhoea | |
126057823 | 12605782 | Hypokalaemia | |
126057823 | 12605782 | Nausea | |
126057823 | 12605782 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126057823 | 12605782 | 1 | 20150101 | 20160110 | 0 | |
126057823 | 12605782 | 2 | 20150101 | 20160110 | 0 | |
126057823 | 12605782 | 3 | 20150101 | 20160101 | 0 |